Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.00% | -198.84% | -65.01% | 0.15% | -643.38% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.81% | 102.99% | 119.49% | -99.33% | 198.45% |
| Change in Net Operating Assets | 58.06% | 121.29% | -5.71% | -109.74% | 227.74% |
| Cash from Operations | -96.95% | -234.86% | 3.58% | -1,964.60% | -627.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -13.00% | -- | -- | -- | 934.50% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.67% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.82% | -- | -- | -100.68% | 2,028.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.70% | 84.54% | 66.30% | -162.54% | 6,537.81% |